Mexico requires pharmaceutical producers to innovate to develop new revenue streams
The market for medicine in Mexico is dominated by the state, creating a challenging environment for drugs producers. However, space exists within the generics market to capture market share outside of the public sphere. In the more advanced segment of biosimilars, companies are looking to the insurance market to open up new market potential. Growth in the generics market has been uneven. In…
